ArticleJHEP reports : innovation in hepatology2022

Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.

Yi Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.